股腘动脉介入治疗进展
Progress in Interventional Treatment of Femoral Popliteal Artery
摘要: 股腘动脉段狭窄闭塞是下肢动脉最常见的发病部位。介入治疗凭借微创、住院周期短等优点逐步成为了患者的首选治疗方式。但由于目前在手术过程中，远期股腘动脉通畅率仍不理想，因此，未来研究仍将重点放在提高股腘动脉通畅率方面。基于此，文章将会对当前腔内治疗的最新进展进行全面的综述，并且结合国内外相关的研究成果展开进一步的分析和探讨。
Abstract: The stenosis and occlusion of the femoropopliteal artery segment is the most common site of onset in lower extremity arteries. Interventional therapy has gradually become the preferred treatment method for patients due to its advantages, such as minimal invasiveness and short hospital stay. However, during the current surgical procedures, the long-term patency rate of the femoropopliteal artery is still not satisfactory. Therefore, future research will still focus on improving the patency rate of the femoropopliteal artery. Based on this, this article will comprehensively review the latest progress in current endovascular treatment and further analyze and discuss it in combination with relevant research results at home and abroad.
文章引用：尹颖异, 李刚. 股腘动脉介入治疗进展[J]. 临床医学进展, 2025, 15(3): 99-107. https://doi.org/10.12677/acm.2025.153592

参考文献

[1] Kamenskiy, A.V., Pipinos, I.I., Dzenis, Y.A., Phillips, N.Y., Desyatova, A.S., Kitson, J., et al. (2015) Effects of Age on the Physiological and Mechanical Characteristics of Human Femoropopliteal Arteries. Acta Biomaterialia, 11, 304-313. [Google Scholar] [CrossRef] [PubMed]
[2] Rocha‐Singh, K.J., Jaff, M.R., Crabtree, T.R., Bloch, D.A. and Ansel, G. (2007) Performance Goals and Endpoint Assessments for Clinical Trials of Femoropopliteal Bare Nitinol Stents in Patients with Symptomatic Peripheral Arterial Disease. Catheterization and Cardiovascular Interventions, 69, 910-919. [Google Scholar] [CrossRef] [PubMed]
[3] Block, P.C., Myler, R.K., Stertzer, S. and Fallon, J.T. (1981) Morphology after Transluminal Angioplasty in Human Beings. New England Journal of Medicine, 305, 382-385. [Google Scholar] [CrossRef] [PubMed]
[4] Rocha‐Singh, K.J., Zeller, T. and Jaff, M.R. (2014) Peripheral Arterial Calcification: Prevalence, Mechanism, Detection, and Clinical Implications. Catheterization and Cardiovascular Interventions, 83, E212-220. [Google Scholar] [CrossRef] [PubMed]
[5] Dua, A. and Lee, C.J. (2016) Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia. Techniques in Vascular and Interventional Radiology, 19, 91-95. [Google Scholar] [CrossRef] [PubMed]
[6] Okuno, S., Iida, O., Shiraki, T., Fujita, M., Masuda, M., Okamoto, S., et al. (2016) Impact of Calcification on Clinical Outcomes after Endovascular Therapy for Superficial Femoral Artery Disease: Assessment Using the Peripheral Artery Calcification Scoring System. Journal of Endovascular Therapy, 23, 731-737. [Google Scholar] [CrossRef] [PubMed]
[7] Donas, K.P. and AbU Bakr, N. (2022) New Insights in Vessel Preparation Options by the Use of Atherectomy in the Treatment of Calcified Femoropopliteal Lesions. The Journal of Cardiovascular Surgery, 63, 1. [Google Scholar] [CrossRef] [PubMed]
[8] 王爱林, 孟昕, 秦巍. 切割球囊扩张治疗膝下动脉狭窄[J]. 中国血管外科杂志(电子版), 2014, 6(2): 96-8+103.
[9] Poncyljusz, W., Falkowski, A., Safranow, K., Rać, M. and Zawierucha, D. (2013) Cutting-balloon Angioplasty versus Balloon Angioplasty as Treatment for Short Atherosclerotic Lesions in the Superficial Femoral Artery: Randomized Controlled Trial. CardioVascular and Interventional Radiology, 36, 1500-1507. [Google Scholar] [CrossRef] [PubMed]
[10] Cioppa, A., Stabile, E., Popusoi, G., Salemme, L., Cota, L., Pucciarelli, A., et al. (2012) Combined Treatment of Heavy Calcified Femoro-Popliteal Lesions Using Directional Atherectomy and a Paclitaxel Coated Balloon: One-Year Single Centre Clinical Results. Cardiovascular Revascularization Medicine, 13, 219-223. [Google Scholar] [CrossRef] [PubMed]
[11] Baumhäkel, M., Chketia, S. and Kindermann, M. (2018) Treatment of Femoro-Popliteal Lesions with Scoring and Drug-Coated Balloon Angioplasty: 12-Month Results of the Dcb-Trak Registry. Diagnostic and Interventional Radiology, 24, 153-157. [Google Scholar] [CrossRef] [PubMed]
[12] Hong, H., Park, U.J., Roh, Y.N. and Kim, H.T. (2020) Scoring Balloon Reduces the Severity of Dissection and Stent Implantation Rate in Superficial Femoral Artery Angioplasty Compared to Plain Balloon. Vascular and Endovascular Surgery, 55, 135-142. [Google Scholar] [CrossRef] [PubMed]
[13] Mustapha, J.A., Lansky, A., Shishehbor, M., Miles McClure, J., Johnson, S., Davis, T., et al. (2018) A Prospective, Multi‐Center Study of the Chocolate Balloon in Femoropopliteal Peripheral Artery Disease: The Chocolate Bar Registry. Catheterization and Cardiovascular Interventions, 91, 1144-1148. [Google Scholar] [CrossRef] [PubMed]
[14] Shirai, S., Mori, S., Yamaguchi, K., Mizusawa, M., Chishiki, T., Makino, K., et al. (2022) Impact of Chocolate Percutaneous Transluminal Angioplasty Balloon on Vessel Preparation in Drug-Coated Balloon Angioplasty for Femoropopliteal Lesion. CVIR Endovascular, 5, 46. [Google Scholar] [CrossRef] [PubMed]
[15] Kereiakes, D.J., Virmani, R., Hokama, J.Y., Illindala, U., Mena-Hurtado, C., Holden, A., et al. (2021) Principles of Intravascular Lithotripsy for Calcific Plaque Modification. JACC: Cardiovascular Interventions, 14, 1275-1292. [Google Scholar] [CrossRef] [PubMed]
[16] Tepe, G., Brodmann, M., Werner, M., Bachinsky, W., Holden, A., Zeller, T., et al. (2021) Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes from the Randomized Disrupt PAD III Trial. JACC: Cardiovascular Interventions, 14, 1352-1361. [Google Scholar] [CrossRef] [PubMed]
[17] Wong, C.P., Chan, L.P., Au, D.M., Chan, H.W.C. and Chan, Y.C. (2022) Efficacy and Safety of Intravascular Lithotripsy in Lower Extremity Peripheral Artery Disease: A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery, 63, 446-456. [Google Scholar] [CrossRef] [PubMed]
[18] Al-Bawardy, R.F., Waldo, S.W. and Rosenfield, K. (2017) Advances in Percutaneous Therapies for Peripheral Artery Disease: Drug-Coated Balloons. Current Cardiology Reports, 19, 99. [Google Scholar] [CrossRef] [PubMed]
[19] Jia, X., Zhang, J., Zhuang, B., Fu, W., Wu, D., Wang, F., et al. (2016) Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence from the AcoArt I Trial. JACC: Cardiovascular Interventions, 9, 1941-1949. [Google Scholar] [CrossRef] [PubMed]
[20] Kinstner, C.M., Lammer, J., Willfort-Ehringer, A., Matzek, W., Gschwandtner, M., Javor, D., et al. (2016) Paclitaxel-eluting Balloon versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. JACC: Cardiovascular Interventions, 9, 1386-1392. [Google Scholar] [CrossRef] [PubMed]
[21] Katsanos, K., Spiliopoulos, S., Kitrou, P., Krokidis, M. and Karnabatidis, D. (2018) Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 7, e011245. [Google Scholar] [CrossRef] [PubMed]
[22] Nordanstig, J., James, S., Andersson, M., Andersson, M., Danielsson, P., Gillgren, P., et al. (2020) Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease. New England Journal of Medicine, 383, 2538-2546. [Google Scholar] [CrossRef] [PubMed]
[23] Schneider, P.A., Laird, J.R., Doros, G., Gao, Q., Ansel, G. and Brodmann, M. (2019) Mortality Not Correlated with Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon. Journal of Vascular Surgery, 73, 2550-2563. [Google Scholar] [CrossRef] 
[24] Ouriel, K., Adelman, M.A., Rosenfield, K., Scheinert, D., Brodmann, M., Peña, C., et al. (2019) Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease. JACC: Cardiovascular Interventions, 12, 2515-2524. [Google Scholar] [CrossRef] [PubMed]
[25] Secemsky, E.A., Kundi, H., Weinberg, I., Jaff, M.R., Krawisz, A., Parikh, S.A., et al. (2019) Association of Survival with Femoropopliteal Artery Revascularization with Drug-Coated Devices. JAMA Cardiology, 4, 332-340. [Google Scholar] [CrossRef] [PubMed]
[26] Gray, W.A., Jaff, M.R., Parikh, S.A., Ansel, G.M., Brodmann, M., Krishnan, P., et al. (2019) Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years. Circulation, 140, 1145-1155. [Google Scholar] [CrossRef] [PubMed]
[27] Laird, J.R., Katzen, B.T., Scheinert, D., Lammer, J., Carpenter, J., Buchbinder, M., et al. (2012) Nitinol Stent Implantation Vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients with Claudication: Three-Year Follow-Up from the RESILIENT Randomized Trial. Journal of Endovascular Therapy, 19, 1-9. [Google Scholar] [CrossRef] [PubMed]
[28] Gouëffic, Y., Della Schiava, N., Thaveau, F., Rosset, E., Favre, J., Salomon du Mont, L., et al. (2017) Stenting or Surgery for De Novo Common Femoral Artery Stenosis. JACC: Cardiovascular Interventions, 10, 1344-1354. [Google Scholar] [CrossRef] [PubMed]
[29] Gouëffic, Y., Torsello, G., Zeller, T., Esposito, G., Vermassen, F., Hausegger, K.A., et al. (2022) Efficacy of a Drug-Eluting Stent versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial. Circulation, 146, 1564-1576. [Google Scholar] [CrossRef] [PubMed]
[30] Dake, M.D., Ansel, G.M., Jaff, M.R., Ohki, T., Saxon, R.R., Smouse, H.B., et al. (2016) Durable Clinical Effectiveness with Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation, 133, 1472-1483. [Google Scholar] [CrossRef] [PubMed]
[31] Dake, M.D., Ansel, G.M., Jaff, M.R., Ohki, T., Saxon, R.R., Smouse, H.B., et al. (2013) Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions: 2-Year Follow-Up from the Zilver PTX Randomized and Single-Arm Clinical Studies. Journal of the American College of Cardiology, 61, 2417-2427. [Google Scholar] [CrossRef] [PubMed]
[32] Zeller, T., Rastan, A., Macharzina, R., Tepe, G., Kaspar, M., Chavarria, J., et al. (2014) Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Long Femoropopliteal Lesions. Journal of Endovascular Therapy, 21, 359-368. [Google Scholar] [CrossRef] [PubMed]
[33] Bausback, Y., Wittig, T., Schmidt, A., Zeller, T., Bosiers, M., Peeters, P., et al. (2019) Drug-Eluting Stent versus Drug-Coated Balloon Revascularization in Patients with Femoropopliteal Arterial Disease. Journal of the American College of Cardiology, 73, 667-679. [Google Scholar] [CrossRef] [PubMed]
[34] Madassery, S., Turba, U.C. and Arslan, B. (2016) Role of Stent Grafts and Helical-Woven Bare-Metal Stents in the Superficial Femoral and Popliteal Arteries. Techniques in Vascular and Interventional Radiology, 19, 153-162. [Google Scholar] [CrossRef] [PubMed]
[35] Hu, C., Chen, L., Wu, M., Ye, Q., Zou, J., Zhao, B., et al. (2024) Efficacy and Safety of Covered Stents versus Bare-Metal Stents for Aortoiliac Occlusive Disease: A Systematic Review and Meta-Analysis. Journal of Endovascular Therapy. [Google Scholar] [CrossRef] [PubMed]
[36] Lammer, J., Zeller, T., Hausegger, K.A., Schaefer, P.J., Gschwendtner, M., Mueller-Huelsbeck, S., et al. (2013) Heparin-Bonded Covered Stents versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions. Journal of the American College of Cardiology, 62, 1320-1327. [Google Scholar] [CrossRef] [PubMed]
[37] Ichihashi, S., Takahara, M., Iida, O., Suzuki, K., Yamaoka, T., Maeda, K., et al. (2021) Clinical Impact of Stent Graft Thrombosis in Femoropopliteal Arterial Lesions. JACC: Cardiovascular Interventions, 14, 1137-1147. [Google Scholar] [CrossRef] [PubMed]
[38] Katsanos, K., Al-Lamki, S.A.M., Parthipun, A., Spiliopoulos, S., Patel, S.D., Paraskevopoulos, I., et al. (2016) Peripheral Stent Thrombosis Leading to Acute Limb Ischemia and Major Amputation: Incidence and Risk Factors in the Aortoiliac and Femoropopliteal Arteries. CardioVascular and Interventional Radiology, 40, 351-359. [Google Scholar] [CrossRef] [PubMed]
[39] Onuma, Y. and Serruys, P.W. (2011) Bioresorbable Scaffold. Circulation, 123, 779-797. [Google Scholar] [CrossRef] [PubMed]
[40] Silingardi, R., Lauricella, A., Coppi, G., Nicolosi, E., Gennai, S. and Coppi, G. (2015) Midterm Results of Endovascular Treatment of Superficial Femoral Artery Disease with Biodegradable Stents: Single-Center Experience. Journal of Vascular and Interventional Radiology, 26, 374-381.e1. [Google Scholar] [CrossRef] [PubMed]
[41] 杨炎, 张针锋, 王俊伟, 等. 可降解金属血管支架的研发进展[J]. 中南大学学报(医学版), 2024: 1-8.
[42] McKinsey, J.F., Zeller, T., Rocha-Singh, K.J., Jaff, M.R. and Garcia, L.A. (2014) Lower Extremity Revascularization Using Directional Atherectomy. JACC: Cardiovascular Interventions, 7, 923-933. [Google Scholar] [CrossRef] [PubMed]
[43] Roberts, D., Niazi, K., Miller, W., Krishnan, P., Gammon, R., Schreiber, T., et al. (2014) Effective Endovascular Treatment of Calcified Femoropopliteal Disease with Directional Atherectomy and Distal Embolic Protection: Final Results of the DEFINITIVE Ca++ Trial. Catheterization and Cardiovascular Interventions, 84, 236-244. [Google Scholar] [CrossRef] [PubMed]
[44] Zeller, T., Langhoff, R., Rocha-Singh, K.J., Jaff, M.R., Blessing, E., Amann-Vesti, B., et al. (2017) Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency. Circulation: Cardiovascular Interventions, 10, e004848. [Google Scholar] [CrossRef] [PubMed]
[45] Wissgott, C., Kamusella, P, Lüdtke, C., et al. (2013) Excimer Laser Atherectomy after Unsuccessful Angioplasty of TASC C and D Lesions in Femoropopliteal Arteries. The Journal of Cardiovascular Surgery (Torino), 54, 359-365.
[46] Dave, R.M., Patlola, R., Kollmeyer, K., Bunch, F., Weinstock, B.S., Dippel, E., et al. (2009) Excimer Laser Recanalization of Femoropopliteal Lesions and 1-Year Patency: Results of the CELLO Registry. Journal of Endovascular Therapy, 16, 665-675. [Google Scholar] [CrossRef] [PubMed]
[47] Dippel, E.J., Makam, P., Kovach, R., George, J.C., Patlola, R., Metzger, D.C., et al. (2015) Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis. JACC: Cardiovascular Interventions, 8, 92-101. [Google Scholar] [CrossRef] [PubMed]
[48] Diamantopoulos, A. and Katsanos, K. (2014) Atherectomy of the Femoropopliteal Artery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of Cardiovascular Surgery (Torino), 55, 655-665.
[49] Zhen, Y., Chang, Z., Wang, C., Liu, Z. and Zheng, J. (2019) Directional Atherectomy with Antirestenotic Therapy for Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis. Journal of Vascular and Interventional Radiology, 30, 1586-1592. [Google Scholar] [CrossRef] [PubMed]
[50] Kokkinidis, D.G. and Armstrong, E.J. (2020) Current Developments in Endovascular Therapy of Peripheral Vascular Disease. Journal of Thoracic Disease, 12, 1681-1694. [Google Scholar] [CrossRef] [PubMed]
[51] Scheinert, D., Scheinert, S., Sax, J., Piorkowski, C., Bräunlich, S., Ulrich, M., et al. (2005) Prevalence and Clinical Impact of Stent Fractures after Femoropopliteal Stenting. Journal of the American College of Cardiology, 45, 312-315. [Google Scholar] [CrossRef] [PubMed]
[52] Shrikhande, G.V. and McKinsey, J.F. (2008) Use and Abuse of Atherectomy: Where Should It Be Used? Seminars in Vascular Surgery, 21, 204-209. [Google Scholar] [CrossRef] [PubMed]
[53] Suresh, K. (2019) Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia: A Brief Purview. Indian Journal of Vascular and Endovascular Surgery, 6, 147-157. [Google Scholar] [CrossRef] 
[54] Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G.R., Gillespie, I., et al. (2010) Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial: A Survival Prediction Model to Facilitate Clinical Decision Making. Journal of Vascular Surgery, 51, 52S-68S. [Google Scholar] [CrossRef] [PubMed]
[55] Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A. and Fowkes, F.G.R. (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Vascular Surgery, 45, S5-S67. [Google Scholar] [CrossRef] [PubMed]

为你推荐